Compound information
- Natural Products
- ZC1846637
- Molecular Formula
- C21H32N2O5
- Molecular Weight
- 392.231122124 g/mol
- Structure
-
- IUPAC Name
- methyl (2S)-2-[[(2S)-2-(benzyloxycarbonylamino)-4-methyl-pentanoyl]amino]-4-methyl-pentanoate
- InChI
- InChI=1S/C21H32N2O5/c1-14(2)11-17(19(24)22-18(12-15(3)4)20(25)27-5)23-21(26)28-13-16-9-7-6-8-10-16/h6-10,14-15,17-18H,11-13H2,1-5H3,(H,22,24)(H,23,26)/t17-,18-/m0/s1
- InChI Key
- FYKHRTVYUNLJLJ-ROUUACIJSA-N
- SMILES
- COC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1
- Source
- ZINC000004458753
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 28 | Ring Count | 1 |
Heteroatom Count | 7 | Rotatable Bond Count | 10 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 93.73 Å2 | LogP | 3.996 |
LogS | -4.538 | LogD | 4.247 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.857 | Pgp substrate | 0.146 |
HIA | 0.955 | F20 % | 0.989 |
F30 % | 0.201 | Caco-2 | -4.705 |
MDCK | -4.69 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.006 | PPB | 89.173 |
VD | 1.093 | Fu | 1.362 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.003 | CYP1A2 substrate | 0.618 |
CYP2A6 substrate | 0.43 | CYP2B6 substrate | 0.613 |
CYP2C19 inhibitor | 0.802 | CYP2C19 substrate | 0.952 |
CYP2C8 substrate | 0.69 | CYP2C9 inhibitor | 0.511 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.018 |
CYP2D6 substrate | 0.39 | CYP2E1 substrate | 0.21 |
CYP3A4 inhibitor | 0.205 | CYP3A4 substrate | 0.998 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.851 | CL | 6.538 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.007 | Hepatotoxicity | 0.981 |
Mutagenicity | 0.723 | Rat Oral Acute Toxicity | 0.022 |
FDAMDD | 0.157 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.03 | Eye Corrosion | 0.006 |
Eye Irritation | 0.021 | Respiratory Toxicity | 0.003 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.378 | IGC50 | 3.335 |
LC50FM | 3.989 | LC50DM | 4.929 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.114 | NR-AR-LBD | 0.225 |
NR-AhR | 0.004 | NR-Aromatase | 0.083 |
NR-ER | 0.246 | NR-ER-LBD | 0.39 |
NR-PPAR-gamma | 0.287 | SR-ARE | 0.202 |
SR-ATAD5 | 0.4 | SR-HSE | 0.187 |
SR-MMP | 0.165 | SR-p53 | 0.029 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.